CRISPR 2.0: New Gene-Editing Technique Shows 99% Accuracy in Clinical Trials
Researchers at the International Bioethics Institute have unveiled a refined CRISPR-Cas9 variant that dramatically reduces off-target effects, paving the way for safer treatments for hereditary diseases like cystic fibrosis and sickle cell anemia.
Read Full Story โ